Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1

Submit an article Journal homepage

Open access

2,144

Views

CrossRef citations to date

Altmetric

Licensed Vaccines – Research Paper

A multi-centre, post-marketing surveillance study of Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar TCV®) in India

Raghu ReddyMedical Affairs Department, Bharat Biotech International Ltd, Hyderabad, IndiaView further author information

Bhargav ReddyMedical Affairs Department, Bharat Biotech International Ltd, Hyderabad, IndiaView further author information

Vamshi SarangiMedical Affairs Department, Bharat Biotech International Ltd, Hyderabad, IndiaView further author information

Siddharth ReddyMedical Affairs Department, Bharat Biotech International Ltd, Hyderabad, IndiaView further author information

Raches EllaMedical Affairs Department, Bharat Biotech International Ltd, Hyderabad, IndiaView further author information

Krishna Mohan VadrevuMedical Affairs Department, Bharat Biotech International Ltd, Hyderabad, IndiaCorrespondence[email protected]
View further author information

Article: 1947761 | Received 16 Apr 2021, Accepted 20 Jun 2021, Published online: 09 Jul 2021

Cite this article
https://doi.org/10.1080/21645515.2021.1947761
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shipra Chaudhary, Gauri Shankar Shah, Nisha Keshary Bhatta, Prakash Poudel, Basant Rai, Surendra Uranw, Prashant Mani Tripathi, Basudha Khanal, Anup Ghimire, Nikita Rai, Birendra Prasad Gupta, Sridhar Vemula, T. Anh Wartel, Sushant Sahastrabuddhe & Tarun Saluja. (2023) A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal. Human Vaccines & Immunotherapeutics 19:1.
Read now

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references